Regeneron Pharmaceuticals News (NASDAQ:REGN)

Regeneron Pharmaceuticals stock quote | Regeneron Pharmaceuticals company information | Regeneron Pharmaceuticals Stock Chart | Regeneron Pharmaceuticals Stock News

Latest Regeneron Pharmaceuticals News Headlines

Date

Time

Source

Headline

01/23/2008

4:32PM

PRNUS

QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) N
NEW YORK, Jan. 23 /PRNewswire/ -- QED International Associates, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on Monday January 28, 2008 Regeneron Pharmaceuticals Inc. (NASDAQ:REGN... More...>>

06/02/2007

12:00PM

PRNUS

Results of VEGF Trap (Aflibercept) Highlighted at ASCO 2007 Annual Meeting
Regeneron and sanofi-aventis to initiate a large Phase III program in five major tumor types in third quarter 2007 CHICAGO, June 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced encouraging preliminary results from two Phase II... More...>>

10/18/2006

4:05PM

PRNUS

Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
Regeneron Retains U.S. Commercialization Rights, Receives $75 Million Upfront, and Eligible for up to $245 Million of Milestone Payments LEVERKUSEN, Germany and TARRYTOWN, N.Y., Oct. 18 /PRNewswire-FirstCall/ -- Bayer HealthCare (NYSE:BAY) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that the companies... More...>>

03/30/2006

8:00AM

PRNUS

Panel of Industry Experts Discuss Challenges of Finding Cures for Chronic Disease at New York Biotechnology Association 2006 An
Insights to Be Provided From the Perspective of a Disease Advocate, Physician and Biotechnology Company Perspective NEW YORK, March 30 /PRNewswire/ -- The New York Biotechnology Association (NYBA), a not-for-profit trade association dedicated to the development and growth of New York State - based biotechnology related... More...>>

01/10/2005

10:32AM

PRNUS

Sanofi-aventis and Regeneron Pharmaceuticals Reaffirm Development Commitment
Sanofi-aventis and Regeneron Pharmaceuticals Reaffirm Development Commitment PARIS, Jan. 10 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that, following a review of the Vascular Endothelial Growth Factor (VEGF) Trap program, they have reaffirmed their commitment to develop the... More...>>